We have previously shown that PGE2 produced by residential stromal cells in the bone marrow limits DNA damage-induced p53 levels via activation of the cAMP signaling pathway, and we have proposed that this may have detrimental effects on both development and treatment of BCP-ALL [24]. Here, TP53 is linked to acute lymphoblastic leukemia.